News | Advanced Visualization | September 07, 2017

Median Technologies to Lead Roundtable on Applications of iBiopsy for Nonalcoholic Steatohepatitis

Panelists will include four key opinion leaders in the fields of hepatology, liver imaging, biomarker and non-invasive test development and clinical trial design

Median Technologies to Lead Roundtable on Applications of iBiopsy for Nonalcoholic Steatohepatitis

September 7, 2017 — Median Technologies announced that it will lead a scientific and medical roundtable on Sept. 7 in Sophia-Antipolis, France, to discuss the application of its next-generation imaging platform iBiopsy for nonalcoholic steatohepatitis (NASH). The roundtable panel will include four key opinion leaders:

  • Richard Jones, M.D., MRCP, vice president, general medicine, Princeton, N.J. Jones is a GMC-registered physician from the United Kingdom specializing in internal medicine, clinical pharmacology and cardiology. He qualified from the Universities of Cambridge and Oxford and has spent more than 15 years in academic medicine in the UK. Jones has over 70 publications on various aspects of drug development. He worked in early- and late-phase drug development holding senior positions in several major pharmaceutical companies. He has experience in developing novel biomarkers and non-invasive tests and their application to clinical trial methodologies;
  • Rohit Loomba, M.D., MHSc, University of California, San Diego (UCSD). Loomba is a professor of medicine (with tenure), director of hepatology, and vice chief, Division of Gastroenterology at UCSD. He is an internationally recognized thought leader in translational research and innovative clinical trial design in nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH), and in non-invasive assessment of steatosis and fibrosis using advanced imaging modalities;
  • Michael Middleton, M.D., Ph.D., UCSD. Together with others at UCSD, Middleton has developed and improved breath-hold quantitative magnetic resonance (MR) magnitude imaging and spectroscopic methods to assess liver fat, and has developed methods to assess the adequacy of MRI proton density fat fraction (PDFF) and magnetic resonance elastography (MRE) liver stiffness assessment measurements. Middleton and his group use MRI to assess liver fat content in clinical trials for the NASH Clinical Research Network, and he currently serves on the Steering and Radiology Committees of the NASH CRN; and
  • Massimo Pinzani is professor of medicine at University College London (UCL), London, United Kingdom. He is a clinical and translational hepatologist, is the Sheila Sherlock Chair of Hepatology and director of the UCL Institute for Liver and Digestive Health, Division of Medicine.  Pinzani is one of the pioneers in research dedicated to cellular and molecular mechanisms of liver fibrosis and relative diagnostic and therapeutic approaches.

The roundtable will aim at providing scientific and medical insights and recommendations to support the development and strategic positioning of Median's  iBiopsy for NASH.

"Median Technologies is developing imaging biomarkers for the diagnosis and assessment of treatment response of NASH patients during clinical trials that will lead to the development of a companion diagnostic imaging test once a drug has been approved by the FDA [U.S. Food and Drug Administration]. Our plan is to have the imaging biomarker validated during the clinical trial becoming the basis for the companion diagnostic. We have been evaluating various imaging protocols and modalities including CT [computed tomography] contrast imaging and MR elastography combined with novel deep learning methodologies," said Fredrik Brag, CEO of Median Technologies. 

iBiopsy (Imaging Biomarker Phenotyping System) is a platform that combines non-invasive image biomarkers with phenomics. This combination of science and technology can provide insights into development of novel therapies and individualized treatment strategies. iBiopsy can measure disease and treatment response without an invasive and costly biopsy.

For more information: www.mediantechnologies.com

Related Content

News | Advanced Visualization | November 13, 2018
Canon Medical Systems USA and Applied Radiology will host a pair of expert-led forums in high-resolution imaging and...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
The OnSight 3D Extremity System captures weight-bearing 3D extremity exams.
Sponsored Content | Whitepapers | Advanced Visualization | October 24, 2018
The OnSight 3D Extremity System captures weight-bearing 3D extremity exams.
Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last several years as medical image acquisition has moved beyond the exclusive purview of radiology.
Feature | Enterprise Imaging | October 03, 2018 | By Jeff Zagoudis
Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last...
Brainlab and Magic Leap Partner in Digital Surgery
News | Advanced Visualization | September 28, 2018
September 28, 2018 — Brainlab announced a strategic development partnership with Florida-based Magic Leap, a develope
EOS Imaging Installs First Site in Mexico
News | Orthopedic Imaging | September 24, 2018
EOS imaging recently announced the first installation of an EOS system in Mexico, the largest Central American market,...
Artificial Intelligence Provides Faster, Clearer MRI Scans

A new artificial-intelligence-based approach to image reconstruction, called AUTOMAP, yields higher quality images from less data, reducing radiation doses for CT and PET and shortening scan times for MRI. Shown here are MR images reconstructed from the same data with conventional approaches, at left, and AUTOMAP, at right. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

News | Artificial Intelligence | July 17, 2018
A research team with funding from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) has...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
3-D Imaging and Computer Modeling Capture Breast Duct Development

An image of a developing mammary duct. Image courtesy of Andrew Ewald.

News | Breast Imaging | June 28, 2018
A team of biologists has joined up with civil engineers to create what is believed to be the first 3-D computer model...
3D Systems Announces On Demand Anatomical Modeling Service
Technology | Medical 3-D Printing | June 18, 2018
3D Systems announced availability of its new On Demand Anatomical Modeling Service. This new service provides a wide...